Milbar Recalls DCL AHA Lightening Gel Due to GMP Deviations
Milbar Laboratories is recalling 1,608 bottles of DCL AHA Lightening Gel due to Good Manufacturing Practice deviations. The product was distributed nationwide and internationally.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and is voluntary due to GMP deviations without reported illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Milbar Laboratories, Inc. is voluntarily recalling 1,608 bottles of DCL AHA Lightening Gel (hydroquinone 2%), 30 ml/1 fl.oz. The recall is being conducted due to Good Manufacturing Practice (GMP) deviations. The specific lot number is LW110-3 with an expiration date of November 2022.
The affected product was distributed throughout the United States, including Puerto Rico, as well as internationally. The recall was initiated on October 9, 2020, and was classified as FDA Class II by the agency.
Consumers who have this product should stop using it and contact the recalling firm for instructions on return or disposal. The recall status is currently terminated.
The recalled product
- Product
- DCL AHA Lightening Gel (hydroquinone 2%), 30 ml/1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486500471
- Manufacturer
- Milbar Laboratories, Inc.
- Category
- Drug — Dermatologic
- Hazard
- Affected units
- 1,608
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: LW110-3
- Exp. Date Nov-22
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 14 recalled by Milbar Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Milbar Laboratories, Inc.
See all →- ModerateMilbar Recalls Malin+Goetz SPF 30 Face Moisturizer Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Willa Clear Skin Salicylic Acid Tubes Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Willa Pore Perfector Pads Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls DCL SA Scalp Therapy Shampoo Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Malin + Goetz Salicylic Gel Due to GMP Deviations
FDA (Drugs) · 2020-11-25
Same hazard · gmp deviation
See all →- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- ModerateFirst Aid Only hand sanitizing wipes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
- ModerateFirst Aid Only BZK antiseptic towelettes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11